BioSpace News Archive

Business

Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update

Corbus Pharmaceuticals Holdings, Inc., a precision oncology company with a diversified portfolio, provided a corporate update and reported financial results for the quarter ended March 31, 2024.

May 7, 2024
·
10 min read
Genetown

Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of B2M-KO iMSC Line with Enhanced Immunosuppressive Activity & Stealthing Features that May Further Augment the Therapeutic Potential of MSCs in Inflammatory Diseases

Eterna Therapeutics Inc. announces that Raven Hinkel will present at the 27th Annual Meeting of the American Society of Gene & Cell Therapy, taking place in Baltimore, Maryland.

May 7, 2024
·
4 min read
Genetown

Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference

Cue Biopharma, Inc. announced that it will take part in a fireside chat at The Citizens JMP Life Sciences Conference being held in New York, May 13-14, 2024.

May 7, 2024
·
1 min read
Biotech Bay

Pliant Therapeutics Announces Upcoming Presentations at the European Association for the Study of the Liver International Liver Congress™

Pliant Therapeutics, Inc. announced two poster presentations, including a late-breaker, at the upcoming European Association for the Study of the Liver International Liver Congress™ taking place in Milan, Italy from June 5-8, 2024.

May 7, 2024
·
2 min read
Policy

Windtree Therapeutics Regains Compliance with Nasdaq - May 07, 2024

Windtree Therapeutics, Inc. announced it has received a Bid Price Compliance Letter from The Nasdaq Stock Market LLC informing Windtree that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550 for continued listing on The Nasdaq Capital Market.

May 7, 2024
·
5 min read
Drug Development

Sagimet Announces Oral Presentation of Data from the Phase 2b FASCINATE-2 Study of Denifanstat in MASH at EASL International Liver Congress 2024

Sagimet Biosciences Inc. announced a General Session oral presentation of denifanstat Phase 2b FASCINATE-2 study data in metabolic dysfunction-associated steatohepatitis will be given at the European Association for the Study of the Liver International Liver Congress 2024 held in Milan, Italy from June 5-8, 2024.

May 7, 2024
·
5 min read
Bio NC

Creyon Bio to Present Clinical Data on Rapid AI-Enabled Engineering of Oligonucleotide-Based Medicines at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting

Creyon Bio, Inc. announced encouraging clinical data highlighting the use of its custom designed data set paired with artificial intelligence to rapidly engineer an investigational antisense oligonucleotide therapy.

May 7, 2024
·
5 min read
Business

Cogent Biosciences Reports First Quarter 2024 Financial Results

Cogent Biosciences, Inc., a biotechnology company focused on developing precision therapies for genetically defined diseases, provided a business update and announced financial results for the first quarter ended March 31, 2024.

May 7, 2024
·
9 min read
Business

Vaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13

Vaxart, Inc. announced it will provide a business update and report financial results for the first quarter ended March 31, 2024 after the market close on Monday, May 13, 2024.

May 7, 2024
·
1 min read
Business

Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights

Nuvectis Pharma, Inc. reported its financial results for the first quarter 2024 and provided an update on recent business progress.

May 7, 2024
·
8 min read